Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.
about
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioningFenofibrate, a peroxisome proliferator-activated receptor α agonist, alters triglyceride metabolism in enterocytes of mice.Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol.Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver.Treatment with ginger ameliorates fructose-induced Fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway.Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female miceHigh glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes.The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis.
P2860
Q33613330-A30AFD70-D8D6-4248-A92A-812F873B812AQ33944254-7E2BF52D-24C6-44BE-AC7A-63E9E1F5AA7FQ34466387-5B96DDCC-9D43-4F4A-9F10-D1212895D6F6Q34511046-1EBE00B2-908A-4DCE-A0AD-CBD3DA3899A1Q34589234-BCE82722-591A-40E6-BF8E-F3770A7A4E71Q34805517-CE125214-9282-4223-9D5B-C41C2CB6C5D3Q36386635-AA25EB1D-03AE-4740-97BA-CC15E0270EA7Q36411221-26B2D495-3AA3-499B-AA9B-7682C1A73C6FQ36808382-72686B41-9AD2-46AF-89D3-0A952EAF4E08Q37062345-89391FD6-DC74-4FFA-8B38-0969033BD3EAQ37594791-280DB79F-D2E9-44DC-8E20-9E00B2649F38Q39245270-154EB1BC-7099-430A-A29D-7FCA49FE6E06
P2860
Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Fenofibrate increases very low ...... ls in APOE*3-Leiden.CETP mice.
@en
Fenofibrate increases very low ...... ls in APOE*3-Leiden.CETP mice.
@nl
type
label
Fenofibrate increases very low ...... ls in APOE*3-Leiden.CETP mice.
@en
Fenofibrate increases very low ...... ls in APOE*3-Leiden.CETP mice.
@nl
prefLabel
Fenofibrate increases very low ...... ls in APOE*3-Leiden.CETP mice.
@en
Fenofibrate increases very low ...... ls in APOE*3-Leiden.CETP mice.
@nl
P2093
P2860
P356
P1476
Fenofibrate increases very low ...... ls in APOE*3-Leiden.CETP mice.
@en
P2093
Annemarie C E Maas
Elsbet J Pieterman
Hans M G Princen
Jan B van Klinken
José W A van der Hoorn
Marjan J van Erk
Patrick C N Rensen
Silvia Bijland
P2860
P304
25168-25175
P356
10.1074/JBC.M110.123992
P407
P577
2010-05-25T00:00:00Z